Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Biogen Inc | 30.4B | 26.1x | -18.14% |
Biontech SE | 20.7B | 21.3x | --- |
Charles River Laboratories International Inc | 11.8B | 24.8x | +15.57% |
Exelixis Inc | 7.0B | 36.6x | -21.77% |
Genmab A/S | 18.6B | 29.7x | +22.71% |
Grifols SA | 5.5B | 66.2x | --- |
Halozyme Therapeutics Inc | 4.9B | 18.3x | --- |
ICON PLC | 25.4B | 37.4x | +4.68% |
Incyte Corp | 11.6B | 19.5x | +39.11% |
IQVIA Holdings Inc | 42.6B | 32.2x | +46.62% |
Medpace Holdings Inc | 12.3B | 40.3x | +35.10% |
Regeneron Pharmaceuticals Inc | 96.9B | 25.4x | +10.93% |
Vertex Pharmaceuticals Inc | 102.7B | 28.6x | +46.35% |
Alkermes Plc | 4.2B | 8.2x | --- |
Amylyx Pharmaceuticals Inc | 119.3M | 2.5x | --- |
AVROBIO Inc | 54.3M | 4.4x | --- |
Bio-Techne Corp | 10.1B | 46.2x | +23.61% |
Biomarin Pharmaceutical Inc | 15.4B | 76.6x | --- |
Cannabis Bioscience International Holdings Inc | 6.8M | 0.0x | --- |
Catalyst Pharmaceuticals Inc | 1.8B | 24.4x | --- |
Enzon Pharmaceuticals Inc | 6.2M | 63.2x | -60.21% |
Exicure Inc | 4.3M | 0.4x | --- |
Halberd Corp | 5.1M | 3.5x | --- |
Kamada Ltd | 296.0M | 29.3x | -22.48% |
Kiniksa Pharmaceuticals Ltd | 1.3B | 209.9x | --- |
Krystal Biotech Inc | 4.5B | 1,772.9x | --- |
LadRx Corp | 1.2M | 4.0x | --- |
MEI Pharma Inc | 20.3M | 1.0x | --- |
MiMedx Group Inc | 921.4M | 24.3x | --- |
Neurocrine Biosciences Inc | 13.7B | 55.9x | +62.04% |
Oramed Pharmaceuticals Inc | 99.7M | 19.4x | --- |
Organogenesis Holdings Inc | 310.1M | 63.9x | --- |
Protalix Biotherapeutics Inc | 84.0M | 16.6x | --- |
Puma Biotechnology Inc | 242.0M | 11.1x | --- |
Qiagen NV | 9.2B | 27.3x | +12.66% |
Redhill Biopharma Ltd | 13.6M | 0.1x | --- |
Revelation Biosciences Inc | 3.6M | 0.1x | --- |
Spero Therapeutics Inc | 78.7M | 3.6x | --- |
TG Therapeutics Inc | 2.1B | 954.0x | --- |
United Therapeutics Corp | 11.0B | 11.8x | +8.22% |
Vanda Pharmaceuticals Inc | 265.8M | 105.4x | -37.98% |
Viaderma Inc | 12.3M | 0.0x | --- |
Voyager Therapeutics Inc | 413.8M | 2.6x | --- |
180 Life Sciences Corp | 1.5M | 0.0x | --- |
2Seventy Bio Inc | 218.3M | -1.0x | --- |
4D Molecular Therapeutics Inc | 1.2B | -9.0x | --- |
89Bio Inc | 786.6M | -4.1x | --- |
Aadi Bioscience Inc | 43.0M | -0.7x | --- |
Abcellera Biologics Inc | 1.1B | -7.4x | --- |
Companies that have maintained their dividend in the face of falling share price lead to high dividend yields. Attention should be paid to the sustainability of these future payments. Generally companies with high dividend yields are mature, stable companies.
| Company | Dividend Yield |
|---|---|
BIO-TECHNE Corp | 0.50% |
Avid Bioservices Inc | --- |
XOMA Corp | --- |
Alkermes Plc | --- |
Ionis Pharmaceuticals Inc | --- |